CAPN3 p.Leu712Phe
c.2134C>T · rs794727318 · VCV195450
ClinGen expert panel — Limb Girdle Muscular Dystrophy VCEP
Likely Pathogenic for autosomal recessive limb-girdle muscular dystrophy. Applied ACMG criteria (verbatim):
PM2_Supporting PP1_Moderate PM3_Strong PP3 PP4
Curation rationale (ClinGen, verbatim)
The NM_000070.3: c.2134C>T variant in CAPN3 is a missense variant predicted to cause the substitution of leucine by phenylalanine at amino acid position 712, p.(Leu712Phe). The variant has been detected in at least six patients with LGMD2A (PMID: 17562833, 26886200, 30919934; GRASP-LGMD Consortium internal data communication), including in a homozygous state without consanguinity in 3 unrelated patients (1.0 pt; PMID: 17562833, 26886200, 30919934). In a fourth patient, the variant was confirmed in trans with a pathogenic CAPN3 variant (c.1981del, p.(Ile661Ter), 1.0 pt) (PMID: 17562833, 26886200, 30919934) (PM3_Strong). At least one patient with this variant displayed a progressive limb girdle pattern of muscle weakness (PP4). This variant was also observed to segregate with autosomal recessive LGMD in three affected family members from one family (PMID: 17562833; PP1_Moderate). The upper bound of the 95% confidence interval of the Grpmax variant allele frequency in gnomAD v4.1.0 is 0.000007757 (4/1180004 European (non-Finnish) chromosomes), which is less than the ClinGen LGMD VCEP threshold (≤0.0001) (PM2_Supporting). The computational predictor REVEL gives a score of 0.855, which is above the threshold of 0.70 (PP3). In summary, this variant meets the criteria to be classified as Likely Pathogenic for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (specifications v2.0.0; 04/29/2026): PM3_Strong, PP4, PP1_Moderate, PM2_Supporting, PP3.
ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9001 | likely pathogenic ✓ concordant with ClinVar |
|---|---|---|
| REVEL | 0.855 | moderately pathogenic-leaning |
| SaProt | LLR -13.42 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 2 | GERP 1.8, phastCons 1 |
| Regional constraint | o/e 0.96 | unconstrained · MANE · 52 kb · p 0.21 · regional, not allelic |
| Overall | ||
| CADD | 23.9 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CAPN3
- Protein
- p.Leu712Phe
- Coding
- c.2134C>T
- MANE Select
- NM_000070
- dbSNP
- rs794727318
- Type
- single nucleotide variant
- Location
- chr15:42410446 (GRCh38)
- Gene constraint
- LOEUF 0.896 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 79.18 · 5 PDB
- Residue 712
- the 'domain iv' region; a β-strand; the ef-hand 2 domain
Disease context
autosomal recessive limb-girdle muscular dystrophy — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: autosomal recessive diseaseautosomal recessive limb-girdle muscular dystrophy type 2Amuscular dystrophy, limb-girdle, autosomal dominant 4
Similar variants
- CAPN3 p.Leu712= Likely benign ★ same residue
- CAPN3 p.Leu712_Ter822del Likely pathogenic same residue
- CAPN3 c.1115+5G>C Pathogenic ★★★ same condition
- CAPN3 c.1194-2A>G Pathogenic ★★★ same condition
- CAPN3 c.1194-9A>G Pathogenic ★★★ same condition
- CAPN3 c.1746-20C>G Pathogenic ★★★ same condition
- CAPN3 c.1993-1G>A Pathogenic ★★★ same condition
- CAPN3 c.499-1G>A Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/capn3-p-leu712phe (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown